Empowered Funds LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 72.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,924 shares of the company's stock after selling 78,906 shares during the quarter. Empowered Funds LLC's holdings in Cardinal Health were worth $3,524,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. State Street Corp increased its stake in Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after acquiring an additional 627,253 shares during the last quarter. Two Sigma Advisers LP increased its stake in Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock worth $118,197,000 after acquiring an additional 346,362 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec increased its stake in Cardinal Health by 230.0% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock worth $52,819,000 after acquiring an additional 333,095 shares during the last quarter. Worldquant Millennium Advisors LLC increased its stake in Cardinal Health by 77.3% during the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company's stock worth $65,539,000 after acquiring an additional 258,541 shares during the last quarter. Finally, Pacer Advisors Inc. increased its stake in Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock worth $474,203,000 after acquiring an additional 191,568 shares during the last quarter. 87.17% of the stock is owned by institutional investors.
Cardinal Health Trading Down 0.3 %
Shares of NYSE CAH traded down $0.44 during trading hours on Friday, reaching $126.35. The stock had a trading volume of 1,620,302 shares, compared to its average volume of 2,327,426. The firm has a market cap of $30.52 billion, a price-to-earnings ratio of 23.57, a P/E/G ratio of 1.49 and a beta of 0.63. The business's fifty day moving average price is $122.85 and its two-hundred day moving average price is $116.41. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. Cardinal Health's dividend payout ratio is currently 37.69%.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Mizuho assumed coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective on the stock. Deutsche Bank Aktiengesellschaft boosted their target price on Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research report on Monday, November 4th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. StockNews.com lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd. Finally, Barclays boosted their target price on Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $136.87.
Read Our Latest Analysis on CAH
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
